US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 93.000
  • +2.270+2.50%
Close Apr 26 16:00 ET
  • 94.990
  • +1.990+2.14%
Post 19:13 ET
5.84BMarket Cap-11111P/E (TTM)

Blueprint Medicines Key Stats

Blueprint Medicines Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 2, 2024

Revenue(YoY)

81.44M

+28.69%
EPS(YoY)

-1.65

+23.37%

Buy

Apr 27, 2024

Blueprint Medicines Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 93.069M--
May 2, 20242024/Q1-- / 81.445M--
Feb 15, 20242023/Q471.957M / 67.103M--
Oct 26, 20232023/Q356.566M / 50.652M--
Aug 2, 20232023/Q257.570M / 45.603M--
May 4, 20232023/Q163.287M / 41.853M--
Feb 16, 20232022/Q438.781M / 33.521M--
--2022/Q365.977M / 43.876M--
Aug 2, 20222022/Q236.547M / 37.613M--
May 3, 20222022/Q162.731M / 39.983M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 93.069M--
May 2, 20242024/Q1-- / 81.445M--
Feb 15, 20242023/Q471.957M / 67.103M--
Oct 26, 20232023/Q356.566M / 50.652M--
Aug 2, 20232023/Q257.570M / 45.603M--
May 4, 20232023/Q163.287M / 41.853M--
Feb 16, 20232022/Q438.781M / 33.521M--
--2022/Q365.977M / 43.876M--
Aug 2, 20222022/Q236.547M / 37.613M--
May 3, 20222022/Q162.731M / 39.983M--

Unlock Free Earnings Estimates

Blueprint Medicines Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 27, 2024

Buy

  • Buy

    66.67%
  • Hold

    16.67%
  • Sell

    16.67%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg